Extensive data demonstrates that GSK3 plays a significant role in AD pathogenesis, impacting tau hyperphosphorylation, memory loss, intracellular Aβ accumulation, and inflammatory responses (Drewes et al., 1995; Wadhwa et al., 2020). Here, MAPT is linked to Alzheimer disease.